Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shrikanth C Basavarajappa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Life Sciences : CMLS|March 5, 2020
Regulation of B-cell function by NF-kappaB c-Rel in health and diseaseShrikanth C Basavarajappa, Parameswaran Ramakrishnan
STAR Protocols|February 28, 2023
Inhibition of SARS-CoV-2 infection in cellular systems using engineered trimeric receptor-binding domain of spike proteinAngela Rose Liu, Shrikanth C Basavarajappa, Nandini Sarkar, et al.
Cellular and Molecular Life Sciences : CMLS|October 25, 2021
Sam68 contributes to intestinal inflammation in experimental and human colitisWendy A Goodman, Shrikanth C Basavarajappa, Angela R Liu, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cellsLiqun Zhang, Santosh K Ghosh, Shrikanth C Basavarajappa, et al.
Iscience|February 7, 2022
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19Liqun Zhang, Santosh K Ghosh, Shrikanth C Basavarajappa, et al.
Iscience|July 11, 2022
Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entryShrikanth C Basavarajappa, Angela Rose Liu, Anna Bruchez, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|March 5, 2020
Regulation of B-cell function by NF-kappaB c-Rel in health and diseaseShrikanth C Basavarajappa, Parameswaran Ramakrishnan
STAR Protocols|February 28, 2023
Inhibition of SARS-CoV-2 infection in cellular systems using engineered trimeric receptor-binding domain of spike proteinAngela Rose Liu, Shrikanth C Basavarajappa, Nandini Sarkar, et al.
Cellular and Molecular Life Sciences : CMLS|October 25, 2021
Sam68 contributes to intestinal inflammation in experimental and human colitisWendy A Goodman, Shrikanth C Basavarajappa, Angela R Liu, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cellsLiqun Zhang, Santosh K Ghosh, Shrikanth C Basavarajappa, et al.
Iscience|February 7, 2022
HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19Liqun Zhang, Santosh K Ghosh, Shrikanth C Basavarajappa, et al.
Iscience|July 11, 2022
Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entryShrikanth C Basavarajappa, Angela Rose Liu, Anna Bruchez, et al.
Pageof 1